340 related articles for article (PubMed ID: 16182129)
1. Toward immunomodulatory and anti-inflammatory properties of statins.
Arnaud C; Braunersreuther V; Mach F
Trends Cardiovasc Med; 2005 Aug; 15(6):202-6. PubMed ID: 16182129
[TBL] [Abstract][Full Text] [Related]
2. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?
Schönbeck U; Libby P
Circulation; 2004 Jun; 109(21 Suppl 1):II18-26. PubMed ID: 15173059
[TBL] [Abstract][Full Text] [Related]
3. Microcirculation as a target for the anti-inflammatory properties of statins.
Scalia R; Stalker TJ
Microcirculation; 2002 Dec; 9(6):431-42. PubMed ID: 12483541
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulation by statins: mechanisms and potential impact on autoimmune diseases.
Chow SC
Arch Immunol Ther Exp (Warsz); 2009; 57(4):243-51. PubMed ID: 19578811
[TBL] [Abstract][Full Text] [Related]
5. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?
März W; Köenig W
J Cardiovasc Risk; 2003 Jun; 10(3):169-79. PubMed ID: 12775949
[TBL] [Abstract][Full Text] [Related]
6. Statins and autoimmune diseases.
Gurevich VS; Shovman O; Slutzky L; Meroni PL; Shoenfeld Y
Autoimmun Rev; 2005 Mar; 4(3):123-9. PubMed ID: 15823497
[TBL] [Abstract][Full Text] [Related]
7. Influence of statins on MHC class I expression.
Singh P; Kohr D; Kaps M; Blaes F
Ann N Y Acad Sci; 2009 Sep; 1173():746-51. PubMed ID: 19758224
[TBL] [Abstract][Full Text] [Related]
8. Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions.
Mason RP; Walter MF; Day CA; Jacob RF
Am J Cardiol; 2005 Sep; 96(5A):11F-23F. PubMed ID: 16126019
[TBL] [Abstract][Full Text] [Related]
9. [The role of HMG-CoA reductase inhibitors in regulation of the inflammatory processes].
Cecha J; Drabek G; Błazelonis A; Romanowski W; Zubelewicz-Szkodzińska B
Wiad Lek; 2004; 57(5-6):255-8. PubMed ID: 15518071
[TBL] [Abstract][Full Text] [Related]
10. The beneficial effects of statins in autoimmune disease therapy.
Marai I; Shoenfeld Y
Drug News Perspect; 2007 Apr; 20(3):165-9. PubMed ID: 17520093
[TBL] [Abstract][Full Text] [Related]
11. The molecular basis of vulnerable plaque: potential therapeutic role for immunomodulation.
Wilensky RL; Hamamdzic D
Curr Opin Cardiol; 2007 Nov; 22(6):545-51. PubMed ID: 17921743
[TBL] [Abstract][Full Text] [Related]
12. Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer.
Graaf MR; Richel DJ; van Noorden CJ; Guchelaar HJ
Cancer Treat Rev; 2004 Nov; 30(7):609-41. PubMed ID: 15531395
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory strategies in coronary atherosclerosis.
Burton PB; Daniel TO
Curr Opin Investig Drugs; 2002 Dec; 3(12):1725-8. PubMed ID: 12528306
[TBL] [Abstract][Full Text] [Related]
14. Effects of statins beyond lipid lowering: potential for clinical benefits.
Almuti K; Rimawi R; Spevack D; Ostfeld RJ
Int J Cardiol; 2006 Apr; 109(1):7-15. PubMed ID: 16054715
[TBL] [Abstract][Full Text] [Related]
15. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
Mora S; Ridker PM
Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
[TBL] [Abstract][Full Text] [Related]
16. Statins: the next anti-endotoxin.
Kruger PS
Crit Care Resusc; 2006 Sep; 8(3):223-6. PubMed ID: 16930109
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulation by statins: inhibition of cholesterol vs. isoprenoid biosynthesis.
Kuipers HF; van den Elsen PJ
Biomed Pharmacother; 2007 Aug; 61(7):400-7. PubMed ID: 17643927
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced immunomodulation to affect the development and progression of atherosclerosis: a new opportunity?
Heeneman S; Donners MM; Bai L; Daemen MJ
Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):345-64. PubMed ID: 17338677
[TBL] [Abstract][Full Text] [Related]
19. Pleiotropic effects of statins in atherosclerosis: role on endothelial function, inflammation and immunomodulation.
Arnaud C; Mach F
Arch Mal Coeur Vaiss; 2005 Jun; 98(6):661-6. PubMed ID: 16007821
[TBL] [Abstract][Full Text] [Related]
20. Statins and cancer prevention.
Demierre MF; Higgins PD; Gruber SB; Hawk E; Lippman SM
Nat Rev Cancer; 2005 Dec; 5(12):930-42. PubMed ID: 16341084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
